Safe and Timely Antithrombotic Removal (STAR) Registry
Recruiting
Observational Study
Hemorrhage, Surgical
Hemorrhage Postoperative
Blood Loss, Surgical
Blood Loss, Postoperative
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- CytoSorbents, Inc · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* CytoSorb utilization for antithrombotic removal
* Informed consent for prospective registry participation
Exclusion Criteria:
• Use of CytoSorb for purpose other than antithrombotic removal
Contacts